Risk factors for MACE and bleeding in atrial fibrillation patients undergoing surgery: Insights from the bridge trial.
Liqi ShuNaomi JackAdam de HavenonEric D GoldsteinFarhan KhanThanh N NguyenNils HenningerJames E SieglerChristoph StretzElizabeth PerelsteinNarendra KalaMaheen RanaKaren L FurieJames D DouketisShadi YaghiPublished in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2024)
We identified predictors for MACE and symptomatic bleeding in AF patients undergoing elective procedures. These insights may help guide perioperative decisions to reduce the risk of adverse outcomes.
Keyphrases
- patients undergoing
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- direct oral anticoagulants
- minimally invasive
- heart failure
- coronary artery bypass
- percutaneous coronary intervention
- study protocol
- clinical trial
- phase iii
- phase ii
- randomized controlled trial
- surgical site infection
- coronary artery disease
- acute coronary syndrome
- left ventricular